Abstract:Congenital heart disease (CHD) is the most common type of developmental abnormality in humans, and is a leading cause for substantially increased morbidity and mortality in affected individuals. Increasing studies demonstrates a pivotal role of genetic defects in the pathogenesis of CHD, and presently mutations in more than 60 genes have been associated with CHD. Nevertheless, CHD is of pronounced genetic heterogeneity, and the genetic basis underpinning CHD in a large proportion of patients remains unclear. In the present study, the whole coding exons and splicing donors/acceptors of the MEF2C gene, which codes for a transcription factor essential for normal cardiovascular development, were sequenced in 200 unrelated patients affected with CHD, and a novel heterozygous missense mutation, p.L38P, was identified in an index patient with patent ductus arteriosus (PDA) and ventricular septal defect (VSD). Genetic scan of the mutation carrier's family members available showed that the mutation was present in all affected family members but absent in unaffected family members. Analysis of the proband's pedigree revealed that the mutation co-segregated with PDA, which was transmitted as an autosomal dominant trait with complete penetrance. The mutation changed the amino acid that was completely conserved evolutionarily, and did not exist in 300 unrelated, ethnically-matched healthy individuals used as controls. Functional deciphers by using a dual-luciferase reporter assay system unveiled that the mutant MEF2C protein had a significantly reduced transcriptional activity. Furthermore, the mutation significantly diminished the synergistic activation between MEF2C and GATA4, another cardiac core transcription factor that has been causally linked to CHD. In conclusion, this is the first report on the association of a MEF2C loss-of-function mutation with an increased vulnerability to CHD in humans, which provides novel insight into the molecular mechanisms underlying CHD, implying potential implications for early diagnosis and timely prophylaxis of CHD.

Functional significance of novel variants of the <i>MEF2C</i> gene promoter in congenital ventricular septal defects

Identification and Functional Analysis of Variants of MYH6 Gene Promoter in Isolated Ventricular Septal Defects

Genetic Analysis of the CITED2 Gene Promoter in Isolated and Sporadic Congenital Ventricular Septal Defects.

Molecular and cellular role of variants of the promoter region of HAND1 gene in sporadic and isolated ventricular septal defect

Identification of Variants of ISL1 Gene Promoter and Cellular Functions in Isolated Ventricular Septal Defects

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle

Genetic Analysis of Variants of the MYH6 Gene Promoter in Congenital Atrial Septal Defects

MEF2C Loss-of-function Mutation Contributes to Congenital Heart Defects.

Molecular Mechanisms Of Ellis-Van Creveld Gene Variations In Ventricular Septal Defect

Novel NKX2-5 Mutations Identified in Patients with Congenital Ventricular Septal Defects

Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.

Integrated genomic analysis identifies novel low-frequency <i>cis</i>-regulatory variant rs2279658 associated with VSD risk in Chinese children

Genetic Variants of CITED2 Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification

Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

Characterization of SMAD3 Gene Variants for Possible Roles in Ventricular Septal Defects and Other Congenital Heart Diseases.

Detection and functional characterization of a novel <i>MEF2A</i> variation responsible for familial dilated cardiomyopathy

Identification of a Novel and Functional Mutation in the TBX5 Gene in a Patient by Screening from 354 Patients with Isolated Ventricular Septal Defect.

VEGF C|[minus]|634G polymorphism is associated with protection from isolated ventricular septal defect: case|[ndash]|control and TDT studies

Identification and Functional Verification of CITED2 Gene Promoter Region in Patients with Patent Ductus Arteriosus.